Xiaowei Zang

Merck & Co., Inc., Rahway, NJ, USA (United States) — United States

Medicine · Health Sciences

7h-index270citations15works12.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Respiratory viral infections research(6), Cancer Treatment and Pharmacology(5), Neonatal Respiratory Health Research(3), Multiple Myeloma Research and Treatments(3), Pneumonia and Respiratory Infections(3)

Publications15 total

Clesrovimab in Infants and Children at Increased Risk for Severe RSV Disease
New England Journal of Medicine·2025· 7 cited
Clesrovimab for Prevention of RSV Disease in Healthy Infants
New England Journal of Medicine·2025· 25 cited
Safety and Pharmacokinetics of <scp>MK</scp> ‐8527 in Adults Without <scp>HIV</scp>
Clinical and Translational Science·2025· 1 citedOpen Access
Evaluation of a monoclonal antibody against respiratory syncytial virus, clesrovimab, in infants and children: Comprehensive rationale and study design for the late-stage clinical trials
Contemporary Clinical Trials·2025· 10 cited
Efficacy of monoclonal antibodies and maternal vaccination for prophylaxis of respiratory syncytial virus disease
Communications Medicine·2025· 6 citedOpen Access
167. Phase 3, Randomized, Controlled Trial Evaluating Safety, Efficacy, and Pharmacokinetics (PK) of Clesrovimab in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease
Open Forum Infectious Diseases·2025· 4 citedOpen Access
A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants
The Journal of Infectious Diseases·2024· 34 citedOpen Access
Physiologically-Based Modeling and Interspecies Prediction of Cisplatin Pharmacokinetics
Journal of Pharmaceutical Sciences·2023· 5 citedOpen Access
Prediction of Individual Analgesic Response to Intravenous Lidocaine in Painful Diabetic Peripheral Neuropathy
Clinical Journal of Pain·2021· 7 citedOpen Access
Administration in fed state but not controlled release in the colon increases oral bioavailability of DF030263, a promising drug candidate for chronic lymphocytic leukemia
European Journal of Pharmaceutics and Biopharmaceutics·2021
Interspecies prediction of pharmacokinetics and tissue distribution of doxorubicin by physiologically‐based pharmacokinetic modeling
Biopharmaceutics & Drug Disposition·2020· 17 cited
Prevention of paclitaxel-induced neuropathy by formulation approach
Journal of Controlled Release·2019· 47 citedOpen Access
Quantitative approaches for understanding and minimizing chemotherapy-induced peripheral neuropathy
Rutgers University Community Repository (Rutgers University)·2019Open Access
Physiologically-based modeling and interspecies prediction of paclitaxel pharmacokinetics
Journal of Pharmacokinetics and Pharmacodynamics·2018· 16 cited
Quantitative analysis of lab-to-lab variability in Caco-2 permeability assays
European Journal of Pharmaceutics and Biopharmaceutics·2017· 91 citedOpen Access

Frequent Co-authors

Leonid Kagan(7), Andrew W. Lee(6), Jong Bong Lee(5), Radha Railkar(5), Brian M. Maas(5), Anushua Sinha(5), Octavio Ramilo(4), Kalpit A. Vora(3), Heather J. Zar(3), Luis A. Castagnini(3), Paolo Manzoni(3), Flor M. Muñoz(3), Atheer Zgair(2), Tae Hwan Kim(2), Hwi‐yeol Yun(2), Peter M. Fischer(2), Pavel Gershkovich(2), Shabir A. Madhi(2), Eric A. F. Simões(2), Jose M Novoa Pizarro(2)